Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- IMRX
- Price
- 1.27
- Stock movement up
- +0.02 (1.60%)
- Company name
- Immuneering Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 39.43M
- Ent value
- 5.06M
- Price/Sales
- -
- Price/Book
- 0.68
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -30.98%
- 3 year return
- -40.73%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-18
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
IMRX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.68 |
| EV to Sales | -0.05 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 31.05M |
| EPS (TTM) | -1.95 |
| FCF per share (TTM) | -1357.19 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | -94.42M |
| Gross profit (TTM) | -94.97M |
| Operating income (TTM) | -61.82M |
| Net income (TTM) | -58.07M |
| EPS (TTM) | -1.95 |
| EPS (1y forward) | -1.63 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.58% |
| Operating margin (TTM) | 65.47% |
| Profit margin (TTM) | 61.50% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 45.21M |
| Net receivables | 0.00 |
| Total current assets | 55.26B |
| Goodwill | 6.69M |
| Intangible assets | 357.73K |
| Property, plant and equipment | 0.00 |
| Total assets | 68.56M |
| Accounts payable | 1.94M |
| Short/Current long term debt | 4.24M |
| Total current liabilities | 6.92B |
| Total liabilities | 10.84M |
| Shareholder's equity | 57.72M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -40.50B |
| Capital expenditures (TTM) | 246.44K |
| Free cash flow (TTM) | -40.50B |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -100.60% |
| Return on Assets | -84.70% |
| Return on Invested Capital | -100.04% |
| Cash Return on Invested Capital | -69774.69% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.30 |
| Daily high | 1.30 |
| Daily low | 1.24 |
| Daily Volume | 62K |
| All-time high | 32.84 |
| 1y analyst estimate | 12.42 |
| Beta | -0.40 |
| EPS (TTM) | -1.95 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IMRX | S&P500 | |
| Current price drop from All-time high | -96.13% | -14.12% |
| Highest price drop | -96.86% | -56.47% |
| Date of highest drop | 16 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -75.25% | -11.07% |
| Avg time to new high | 104 days | 12 days |
| Max time to new high | 894 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
39.43M
Marketcap category
Small-cap
Description
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Employees
66
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page